Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00570804 · ClinicalTrials.gov registry record · NA

Combined Treatment for Tobacco and Alcohol Use in Puerto Rico

A NA study, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
370
Enrollment target

NCT00570804: Completed NA study, sponsored by M.D. Anderson Cancer Center.

NCT00570804 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 370 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00570804, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
370 participants
Enrollment target

Study Summary

Objectives: 1. Assess MAPS and MAPS+ effects on alcohol at-risk behaviors and smoking cessation. 2. Assess MAPS and MAPS+ effects on treatment mechanisms (increased self-efficacy, decreased temptations/craving, decreased stress and negative affect) and the role of those mechanisms in mediating MAPS and MAPS+ effects on alcohol at-risk behaviors and smoking cessation. 3. Evaluate the cost-effectiveness of MAPS and MAPS+ in the reduction of at-risk drinking and smoking cessation.

Interventions

  • BEHAVIORAL Telephone Counseling
  • BEHAVIORAL Telephone Assessments

Trial Details

FieldValue
Enrollment Target 370 participants
Start Date 2007-12
Est. Completion 2021-07-22
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT00570804

The ClinicalTrials.gov registry entry for NCT00570804 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 370 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Telephone Counseling is the first listed.

NCT00570804 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00570804 about?

NCT00570804 is a clinical study titled "Combined Treatment for Tobacco and Alcohol Use in Puerto Rico". Objectives: 1. Assess MAPS and MAPS+ effects on alcohol at-risk behaviors and smoking cessation. 2. Assess MAPS and MAPS+ effects on treatment mechanisms (increased self-efficacy, decreased temptations/craving, decreased stress and negative affect) and the role of those mechanisms in mediating MAPS...

What is the current status of trial NCT00570804?

This trial is currently completed. It is a NA study. The enrollment target is 370 participants. The study started on 2007-12. Estimated completion is 2021-07-22.

What interventions are being tested in trial NCT00570804?

The interventions under investigation include: Telephone Counseling (BEHAVIORAL), Telephone Assessments (BEHAVIORAL).

Who is sponsoring clinical trial NCT00570804?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.